NCT00216658View on ClinicalTrials.gov

Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics -

PHASE2CompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

December 31, 2004

Study Completion Date

September 30, 2005

Conditions
Pain, Intractable
Interventions
DRUG

fentanyl

Sponsors
All Listed Sponsors
lead

Janssen Pharmaceutical K.K.

INDUSTRY